Observational studyJournal of neurology2024

Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study.

Massimo Filippi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.